Report Attribute/Metric |
Details |
Base Year For Estimation |
2021 Forecast Period 2023-2032 Historical Data 2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Product, Indication, Application Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors R. Bard, Inc. (US), Johnson & Johnson (UK), Baxter International, Inc. (US), Medtronic plc (US), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (US), Sanofi Group (France), Sealantis, Ltd (Israel), Vivostat A/S (Denmark), and Ocular Therapuetix, Inc. (US) Key Market Opportunities Increasing surgical procedures, development of healthcare infrastructure and investments by industry players Key Market Drivers· Growing prevalence and incidence of various disorders· Growth in the number of accidents· Growth in the number of surgeries |
Historical Data |
2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Product, Indication, Application Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors R. Bard, Inc. (US), Johnson & Johnson (UK), Baxter International, Inc. (US), Medtronic plc (US), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (US), Sanofi Group (France), Sealantis, Ltd (Israel), Vivostat A/S (Denmark), and Ocular Therapuetix, Inc. (US) Key Market Opportunities Increasing surgical procedures, development of healthcare infrastructure and investments by industry players Key Market Drivers· Growing prevalence and incidence of various disorders· Growth in the number of accidents· Growth in the number of surgeries |
Forecast Period |
2023-2032 Historical Data 2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Product, Indication, Application Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors R. Bard, Inc. (US), Johnson & Johnson (UK), Baxter International, Inc. (US), Medtronic plc (US), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (US), Sanofi Group (France), Sealantis, Ltd (Israel), Vivostat A/S (Denmark), and Ocular Therapuetix, Inc. (US) Key Market Opportunities Increasing surgical procedures, development of healthcare infrastructure and investments by industry players Key Market Drivers· Growing prevalence and incidence of various disorders· Growth in the number of accidents· Growth in the number of surgeries |
Growth Rate |
10.4% : 2023-2032 Base Year 2021 Forecast Period 2023-2032 Historical Data 2020 Forecast Units Value (USD Billion Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Product, Indication, Application Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors R. Bard, Inc. (US), Johnson & Johnson (UK), Baxter International, Inc. (US), Medtronic plc (US), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (US), Sanofi Group (France), Sealantis, Ltd (Israel), Vivostat A/S (Denmark), and Ocular Therapuetix, Inc. (US) Key Market Opportunities Increasing surgical procedures, development of healthcare infrastructure and investments by industry players Key Market Drivers· Growing prevalence and incidence of various disorders· Growth in the number of accidents· Growth in the number of surgeries |